HIMA's Candace Littell.
This article was originally published in The Gray Sheet
Littell joins Health Industry Manufacturers Association as senior health policy advisor. Prior to joining HIMA, Littell ran a Washington, D.C. consulting firm, CL Littell & Associates, which focused on payment issues. Littell went into consulting after leaving as executive director of the Health Care Technology Institute at the end of 1994. HCTI, which later closed, was formed by HIMA to study the impact of medical technology on health care costs and productivity. At HIMA, Littell will be working with Ted Mannen, executive VP, health systems, and Greg Raab, who is shifting from FDA reform work as VP, government affairs, to reimbursement issues as senior health affairs advisor...
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.